- Pagina principale
- Analisi delle app
- Ophthalmoscope SEC
- Ophthalmoscope SEC Vs. EyeTakes
Ophthalmoscope SEC vs. EyeTakes Utilizzo e statistiche
Spread the ophthalmologists' view to the world
Blindness continues to remain a major problem worldwide.WHO announced that at least a billion people have a visual impairment that can be prevented or has yet to be addressed. Over half of these blindness incidents were caused by cataracts.
We found that one of the major problems is that there is no diagnostic device in the areas where blindness is increasing.Therefore, we invented a solution that has the potential to overcome this problem. The solution, Smart Eye Camera (SEC), is a smart phone attachment that can record and evaluate ophthalmological images and video to help make a diagnosis online.
The Ophthalmoscope SEC is an attachment to the iPhone that allows the user to view the fundus and diagnose ophthalmologic diseases in the same way as an existing direct-view mirror.
Term and Condition(Japanese Only)
https://www.ouiinc.jp/terms_of_service/
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
Welcome to EyeTakes, an easy to use app that is intended to assist medical professionals in portable indirect fundus and optic disc examination. Designed for application in telemedicine, global health, and for performance of widespread screening exams. Application features include: adjustable camera light, zoom function, picture store and send, and picture markup.
- App Store di Apple
- Gratis
- Salute e fitness
Classifica degli store
- -
Ophthalmoscope SECRanking a confronto con EyeTakes
Confronta la tendenza di classifica Ophthalmoscope SEC nei ultimi 28 giorni rispetto a EyeTakes
Rank
Nessun dato disponibile
Classifica Ophthalmoscope SEC vs. EyeTakes per paese a confronto
Confronta la tendenza di classifica Ophthalmoscope SEC nei ultimi 28 giorni rispetto a EyeTakes
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita
Ophthalmoscope SEC VS.
EyeTakes
30icembre d, 2024